Showing results (71-80 of 80) with videos related to
Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 80 results.
Nature Chemical Biology|April 25, 2017
Global survey of the immunomodulatory potential of common drugsGregory I Vladimer, Berend Snijder, Nikolaus Krall, et al.Wiener Klinische Wochenschrift|March 3, 2012
[Primary immune thrombocytopenia in adults: diagnostics and treatment consensus statement of the Austrian Society of Hematology and Oncology (ÖGHO)]Ingrid Pabinger, Günther Gastl, Michael Steurer, et al.Blood|December 20, 2014
Prognostic factors for remission of and survival in acquired hemophilia A (AHA): results from the GTH-AH 01/2010 studyAndreas Tiede, Robert Klamroth, Rüdiger E Scharf, et al.European Journal of Cancer (Oxford, England : 1990)|July 8, 2026
Management of critically ill cancer patients. Expert consensus statement of the "Intensive Care for Hematology and Oncology Patients" (iCHOP) Working Group of the German Society of Hematology and Oncology (DGHO), Austrian Society of Hematology and Oncology (OeGHO), German Society for Medical Intensive Care Medicine and Emergency Medicine (DGIIN), and Austrian Society of Medical and General Intensive Care and Emergency Medicine (ÖGIAIN)Asterios Tzalavras, Elena Busch, Boris Böll, et al.The New England Journal of Medicine|May 1, 2024
Recombinant ADAMTS13 in Congenital Thrombotic Thrombocytopenic PurpuraMarie Scully, Ana Antun, Spero R Cataland, et al.Blood|June 5, 2024
Management of immune thrombotic thrombocytopenic purpura without therapeutic plasma exchangeLucas Kühne, Paul Knöbl, Kathrin Eller, et al.International Journal of Molecular Sciences|April 30, 2020
Correlation of RAS-Pathway Mutations and Spontaneous Myeloid Colony Growth with Progression and Transformation in Chronic Myelomonocytic Leukemia-A Retrospective Analysis in 337 PatientsKlaus Geissler, Eva Jäger, Agnes Barna, et al.Wiener Klinische Wochenschrift|July 20, 2019
The Austrian biodatabase for chronic myelomonocytic leukemia (ABCMML) : A representative and useful real-life data source for further biomedical researchKlaus Geissler, Eva Jäger, Agnes Barna, et al.Blood|February 11, 2026
Revisiting Clinical Response and Refractoriness in Immune Thrombotic Thrombocytopenic PurpuraLucas Kühne, Thomas Osterholt, Maximilian Suer, et al.Eclinicalmedicine|April 16, 2025
Caplacizumab use in immune-mediated thrombotic thrombocytopenic purpura: an international multicentre retrospective Cohort study (The Capla 1000+ project)Paul Coppo, Michael Bubenheim, Ygal Benhamou, et al.Pageof 8